Gregory P. Kalemkerian

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial”.

Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial

Nature Medicine(2022)10.1038/s41591-022-01931-y

N/A

3.9DataRank · unranked

240 citations

Philippe A. Cassier, Salvatore Siena, Elena Garralda, Luis Paz‐Ares, Pilar Garrido +14 more

Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial

Annals of Oncology(2022)10.1016/j.annonc.2022.08.002

N/A

0.782DataRank · unranked

183 citations

Giuseppe Curigliano, Michael Thomas, Vivek Subbiah, Christina S. Baik, Daniel S.W. Tan +21 more

High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients

Cancers(2020)10.3390/cancers12010127

N/A

0.663DataRank · unranked

82 citations

Maggie Lee, Arthi Nadhan, Anvya Mathur, Casey Hedman, Eric Lin +12 more

Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline

Journal of Clinical Oncology(2023)10.1200/jco.23.01435

N/A

0.593DataRank · unranked

51 citations

Nofisat Ismaila, Jessica Bian, Raetasha Dabney, Millie Das, Peter Ellis +12 more

Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung Cancer

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.06.018

N/A

0.269DataRank · unranked

5 citations

Caitlin A. Schonewolf, John D. Rice, Matthew J. Schipper, Randall K. Ten Haken, M.M. Matuszak +15 more

Data from An Embryonic Stem Cell–Like Signature Identifies Poorly Differentiated Lung Adenocarcinoma but not Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6516963

N/A

0DataRank · unranked

0 citations

Guoan Chen, Gregory P. Kalemkerian, Max S. Wicha, David G. Beer, Khaled A. Hassan

Data from An Embryonic Stem Cell–Like Signature Identifies Poorly Differentiated Lung Adenocarcinoma but not Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6516963.v1

N/A

0DataRank · unranked

0 citations

Guoan Chen, Gregory P. Kalemkerian, Max S. Wicha, David G. Beer, Khaled A. Hassan

Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancer

Scientific Reports(2022)10.1038/s41598-022-13236-8

N/A

0DataRank · unranked

15 citations

Fatima Lima, Samantha L. Bell, Gregory P. Kalemkerian, Bryan J. Schneider, Nithya Ramnath +6 more